BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 35686306)

  • 41. CADM1, MAL, and miR124 Promoter Methylation as Biomarkers of Transforming Cervical Intrapithelial Lesions.
    Del Pino M; Sierra A; Marimon L; Martí Delgado C; Rodriguez-Trujillo A; Barnadas E; Saco A; Torné A; Ordi J
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial Neoplasia.
    Louvanto K; Aro K; Nedjai B; Bützow R; Jakobsson M; Kalliala I; Dillner J; Nieminen P; Lorincz A
    Clin Infect Dis; 2020 Jun; 70(12):2582-2590. PubMed ID: 31344234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk stratification for cervical precancer and cancer by DH3-HPV partial genotyping and cytology in women attending cervical screening: A retrospective cohort study.
    Fu Y; Li Y; Li X; Wang X; Lü W
    J Med Virol; 2023 Feb; 95(2):e28482. PubMed ID: 36609841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genotype-specific methylation of HPV in cervical intraepithelial neoplasia.
    Hsu YW; Huang RL; Su PH; Chen YC; Wang HC; Liao CC; Lai HC
    J Gynecol Oncol; 2017 Jul; 28(4):e56. PubMed ID: 28541643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Risk stratification of type-specific human papillomavirus for cervical precancers: evidence from a cross-sectional study in Shenzhen].
    Liu ZH; Lin W; Wang YY; Wu B; Yuan SX; Yao JL; Zhao XS; Chen B; Qiao YL; Zhao FH; Chen W; Hu SY
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):757-763. PubMed ID: 30392340
    [No Abstract]   [Full Text] [Related]  

  • 46. FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.
    Luttmer R; De Strooper LM; Dijkstra MG; Berkhof J; Snijders PJ; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; van Baal WM; Graziosi PG; Quint WG; Spruijt JW; van Dijken DK; Heideman DA; Meijer CJ
    Br J Cancer; 2016 Aug; 115(5):579-87. PubMed ID: 27415009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Age distribution of HPV genotypes in cervical intraepithelial neoplasia.
    Sideri M; Igidbashian S; Boveri S; Radice D; Casadio C; Spolti N; Sandri MT
    Gynecol Oncol; 2011 Jun; 121(3):510-3. PubMed ID: 21396686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
    Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Role of Methylation of Host and/or Human Papillomavirus (HPV) DNA in Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Lesions.
    Dovnik A; Poljak M
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
    Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
    J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.
    Zhao X; Wu Q; Wang X; Fu Y; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X
    Clin Microbiol Infect; 2018 Dec; 24(12):1322-1327. PubMed ID: 29518562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis.
    Salta S; Lobo J; Magalhães B; Henrique R; Jerónimo C
    Clin Epigenetics; 2023 Aug; 15(1):125. PubMed ID: 37533074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.
    Simonella LM; Lewis H; Smith M; Neal H; Bromhead C; Canfell K
    BMC Infect Dis; 2013 Mar; 13():114. PubMed ID: 23452957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.
    Salta S; Maia-Moço L; Estevão-Pereira H; Sequeira JP; Vieira R; Bartosch C; Petronilho S; Monteiro P; Sousa A; Baldaque I; Rodrigues J; Sousa H; Tavares F; Henrique R; Jerónimo C
    Int J Cancer; 2021 Dec; 149(11):1916-1925. PubMed ID: 34460099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.
    Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N
    Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HPV and DNA Methylation Testing in Urine for Cervical Intraepithelial Neoplasia and Cervical Cancer Detection.
    van den Helder R; Steenbergen RDM; van Splunter AP; Mom CH; Tjiong MY; Martin I; Rosier-van Dunné FMF; van der Avoort IAM; Bleeker MCG; van Trommel NE
    Clin Cancer Res; 2022 May; 28(10):2061-2068. PubMed ID: 35266975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.
    Mariano VS; Lorenzi AT; Scapulatempo-Neto C; Stein MD; Resende JC; Antoniazzi M; Villa LL; Levi JE; Longatto-Filho A; Fregnani JH
    PLoS One; 2016; 11(10):e0164892. PubMed ID: 27764154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Value of HPV 16/18 Genotyping and p16/Ki-67 Dual Staining to Predict Progression to HSIL/CIN2+ in Negative Cytologies From a Colposcopy Referral Population.
    Rodríguez-Trujillo A; Martí C; Angeles MA; Sierra A; Esteve R; Saco A; Barnadas E; Marimón L; Nicolás I; Torné A; Ordi J; Del Pino M
    Am J Clin Pathol; 2018 Oct; 150(5):432-440. PubMed ID: 30052715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
    BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study.
    Fujii T; Saito M; Hasegawa T; Iwata T; Kuramoto H; Kubushiro K; Ohmura M; Ochiai K; Arai H; Sakamoto M; Motoyama T; Aoki D
    Int J Clin Oncol; 2015 Feb; 20(1):134-42. PubMed ID: 24744261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.